NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Insurance - Life · USD

MetLife, Inc. (MET) Stock Analysis

MetLife, Inc. (MET) is a Insurance - Life stock listed on NYSE and quoted in US Dollar.

MET

$97.62

−$1.61 (−1.62%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare MET with… →

MET Key Statistics

As of Sep 4, 2026
Trading
Open
$98.34
Previous Close
$99.23
Day's Range
97.47–99.13
52-Week Range
67.33–100.93
Volume
2.66M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.76
Valuation
Market Cap
$62.04B
P/E Ratio
19.03
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
8.94
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.50
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.78
EPS (ttm)Profit attributable to each share over the last twelve months.
5.13
Financials (FY)
Revenue (FY)
$75.65B+7.88%
Net Income (FY)
$3.38B−23.66%
Profit marginThe share of revenue left as profit after all costs and taxes.
4.57%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
635.48M
1-Year Return
+22.82%
Dividend and dates
Dividend
$2.37+2.39%
Ex-Dividend Date
August 4, 2026
Earnings Date
November 9, 2026
Avg Volume
3.65M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

MET Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+26.28%
2025−0.80%
2024+27.68%
2023−5.49%
2022+19.23%
2021+37.43%
2020−3.42%
2019+28.84%
2018−15.77%
2017+8.42%
2016 (partial year)+31.11%

As of September 4, 2026.

MET Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$75.65B$3.38B4.5%
2024$70.13B$4.43B6.3%
2023$67.93B$1.58B2.3%
2022$67.41B$5.28B7.8%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$75.65B——$3.38B4.5%
2024$70.13B——$4.43B6.3%
2023$67.93B——$1.58B2.3%
2022$67.41B——$5.28B7.8%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

MET Dividend History

$2.25+4.4% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$1.753—
2025$2.254+4.4%
2024$2.164+4.6%
2023$2.064+4.0%
YearDividends per sharePaymentsChange
2026 (partial year)$1.753—
2025$2.254+4.4%
2024$2.164+4.6%
2023$2.064+4.0%
2022$1.984+4.2%
2021$1.904+4.4%
2020$1.824+4.6%
2019$1.744+4.8%
2018$1.664+13.0%
2017$1.474+312.2%
2016$0.361—

Most recent payment: $0.58 per share, ex-dividend August 4, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

MET Valuation vs Insurance - Life Median

Median of 26 stocks
MetricMETInsurance - Life medianvs median
P/E19.0311.4067% above
P/S ratio0.781.1331% below
Profit margin4.57%11.35%6.8 pts below

Medians across 26 Insurance - Life stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

MetLife, Inc. (MET) is capitalised at $62.04B on the latest close. The company sits in the Financial Services sector, in the Insurance - Life industry. The company reports 46,000 employees.

The 52-week range on file runs from $67.33 to $100.93. MET last closed at $97.62 on September 4, 2026. That is −$1.61 (−1.62%) against the previous close. The latest close sits 44.99% above that 52-week low.

Financial Health

In fiscal 2025, MetLife, Inc. reported revenue of $75.65B. That is +7.88% against the prior fiscal year, when revenue was $70.13B. The same year closed with net income of $3.38B. That is −23.66% against the prior fiscal year. The reported profit margin is 4.57%. That is 6.8 percentage points below the Insurance - Life median of 11.35%. Trailing earnings per share are 5.13.

Across the 4 fiscal years on file, revenue moves from $67.41B in 2022 to $75.65B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

MET trades at a trailing price-to-earnings ratio of 19.03. That is 66.93% above the Insurance - Life median of 11.4. The forward P/E on file is 8.94. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.5. Measured against sales, the shares trade at 0.78 times revenue. On price-to-sales that is 31.06% below the Insurance - Life median of 1.13. The medians here are taken across 26 Insurance - Life companies that report the metric.

The reported beta is 0.76. Annualized volatility over the trailing 10 years is 29.96%. The trailing one-year price return is +22.82%. Across 10 years the annualized return works out at +13.47%.

Growth & Income

MET pays a dividend yielding 2.39%. That is 0.3 percentage points below the Insurance - Life median yield of 2.68%. The indicated annual rate is $2.37 a share. The ex-dividend date on file is August 4, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $1.75 a share. The year before, 2025, totalled $2.25 a share.

So far in 2026 the price is +26.28%. Across the complete calendar years on file, 2021 returned +37.43% and 2018 returned −15.77%. Of the 9 complete calendar years on file, 5 finished higher.

Peer Comparison

MetLife, Inc. (MET) operates in the Insurance - Life industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
MetLife, Inc. MET $62.04B 19.0
Great-West Lifeco Inc. GWO.TO $82.89B 19.1
Manulife Financial Corporation MFC $73.57B 16.8
Power Corporation of Canada POW.TO $59.81B 23.5

The Insurance - Life industry average P/E ratio is 11.4x. MetLife, Inc. trades at a P/E of 19.0.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Insurance - Life Stocks

GWO.TO

Great-West Lifeco Inc.

$82.89B

 MFC

Manulife Financial Corporation

$73.57B

 POW.TO

Power Corporation of Canada

$59.81B

 AFL

Aflac Incorporated

$58.76B

 PRU

Prudential Financial, Inc.

$42.10B

 PUK

Prudential plc

$34.39B
View all Insurance - Life stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

 JPM

JPMorgan Chase & Co.

$953.33B

 V

Visa Inc.

$700.27B

 MA

Mastercard Incorporated

$507.39B

 BAC

Bank of America Corporation

$438.31B
View all Financial Services stocks →

About MetLife, Inc.

MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates in six segments: Group Benefits; Retirement and Income Solutions; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment, accident and health, vision, and pet insurance, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it offers fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity and funded reinsurance solutions; credit insurance products; accident & health products covering hospitalization, cancer, critical illness, income protection, and scheduled medical reimbursement plans; and protection against long-term health care services. The company was incorporated in 1999 and is based in New York, New York.

Visit website →